Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Products
  • 研究・開発
  • タンパク質解析
  • イムノアッセイ
  • Alphaアッセイ
  • AlphaLISA Human IL-17A High Performance & Biotin Free Detection Kit, 500 Assay Points

AlphaLISA Human IL-17A High Performance & Biotin Free Detection Kit, 500 Assay Points

AlphaLISA Biotin Free image
Video Play Button
AlphaLISA Human IL-17A High Performance & Biotin Free Detection Kit, 500 Assay Points
AlphaLISA Biotin Free image
Video Play Button
AlphaLISA Biotin Free image
AlphaLISA Biotin Free
AlphaLISA Biotin Free image
AlphaLISA Biotin Free image
Video Play Button

The AlphaLISA™ High Performance (HP) Biotin-Free Human IL-17A Detection Kit is designed for the quantitative determination of human IL-17A in serum, buffered solution, or cell culture medium using a homogeneous (no wash steps, no separation steps) assay.

This kit is the new and improved version of part number AL346.

View product information
Feature Specification
Application Protein Quantification
Dynamic Range 4.58 - 300,000 pg/mL  
Limit of Detection 4.58 pg/mL  
Limit of Quantification 19.42 pg/mL  
Sample Volume 5 µL

The AlphaLISA™ High Performance (HP) Biotin-Free Human IL-17A Detection Kit is designed for the quantitative determination of human IL-17A in serum, buffered solution, or cell culture medium using a homogeneous (no wash steps, no separation steps) assay.

This kit is the new and improved version of part number AL346.

View product information
Product variants
Unit Size: 100 assay points
Part #:
AL3162HV
Unit Size: 500 assay points
Part #:
AL3162C
Unit Size: 5,000 assay points
Part #:
AL3162F
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption, and disposal requirements under European REACH regulations (EC 1907/2006).
Request more information
AlphaLISA Biotin Free image
AlphaLISA Biotin Free image
Video Play Button
AlphaLISA Human IL-17A High Performance & Biotin Free Detection Kit, 500 Assay Points
AlphaLISA Biotin Free image
Video Play Button
AlphaLISA Biotin Free image
AlphaLISA Biotin Free
AlphaLISA Human IL-17A High Performance & Biotin Free Detection Kit, 500 Assay Points
AlphaLISA Biotin Free image
AlphaLISA Biotin Free image
Video Play Button
Quick links
  • Variants
  • Video
  • Product information
  • Resources
  • SDS, COAs, manuals and more
  • Related products
  • Recently viewed
  • Customers also bought
  • Get help

Product information

  • Overview
  • How it works
  • Specifications
  • Video gallery

Overview

Human Interleukin 17 (IL-17 or IL-17A) is a homodimer formed by two ~15 kDa subunits produced by a subset of T helper cells named Th17. It is a proinflammatory cytokine that enhances T-cell priming and stimulates macrophages, fibroblasts, endothelial, and epithelial cells to produce multiple mediators of inflammation such as IL-1, IL-6, TNF-α, NOS-2, metalloproteases, and chemokines. IL-17 has been implicated in the proinflammatory patterns associated with joint inflammation and rheumatoid arthritis (RA) in mouse and human models. It is also critical for neutrophil activation and migration, and induces IL-8, a key chemokine for neutrophils. IL-17 signals through IL-17R, which in mice has at least two members, IL-17RA, and IL-17RC. Recent studies suggest that the IL-17 pathway may be a novel therapeutic target for the treatment of chronic inflammatory diseases like asthma and RA.

Formats
  • Our 100 assay point kit allows you to run 100 wells in 96-well format, using a 100 µL reaction volume (10 µL of sample).
  • Our 500 assay point kit allows you to run 500 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).
  • Our 5,000 assay point kit allows you to run 5,000 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).
Features
  • No-wash steps, no separation steps
  • ELISA alternative technology
  • Sensitive detection
  • Broad sample compatibility
  • Small sample volume
  • Results in less than 3 hours
  • Half the time of an ELISA assay

AlphaLISA technology allows the detection of molecules of interest in a no-wash, highly sensitive, quantitative assay. In an AlphaLISA biotin-free assay, a DIG-labeled anti-analyte antibody binds to the anti-DIG-coated Donor beads while another anti-analyte antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads causes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.

How it works

Principle of the AlphaLISA biotin-free assay

The AlphaLISA Biotin-Free assay is based on an AlphaLISA sandwich immunoassay involving a digoxigenin anti-analyte antibody bound to anti-DIG AlphaLISA Donor beads and an anti-analyte antibody conjugated to AlphaLISA Acceptor beads. Both antibodies are directed against the analyte of interest. In the presence of the target, both antibodies bind to analyte and the beads come into proximity. The excitation of the Donor beads provokes the release of singlet oxygen molecules that triggers a cascade of energy transfer within the Acceptor beads, resulting in emission with λmax at 615 nm. The intensity of the signal is directly proportional to the concentration of analyte present in the sample.

AlphaLISA DIG Assay Principle

 

Protocol of the AlphaLISA biotin-free assay

The AlphaLISA Biotin-Free assay can be run in a 96- or 384-well detection plate (50 µL final). As described here, samples or standards are dispensed directly into the assay plate for the detection of the analyte of interest by AlphaLISA reagents. No washing steps are needed. The protocol can be further miniaturized or upscaled by simply resizing each addition volume proportionally.

img-protocol-alphalisa-2-step-dig

Specifications

Application
Protein Quantification
Automation Compatible
Yes
Brand
AlphaLISA
Detection Modality
Alpha
Dynamic Range
4.58 - 300,000 pg/mL  
Limit of Detection
4.58 pg/mL  
Limit of Quantification
19.42 pg/mL  
Product Group
Kit
Sample Volume
5 µL
Shipping Conditions
Shipped in Blue Ice
Target
IL-17A
Target Class
Cytokines
Target Species
Human
Technology
Alpha
Therapeutic Area
Autoimmunity
Inflammation
Neuroscience
Unit Size
500 assay points

Video gallery

AlphaLISA Human IL-17A High Performance & Biotin Free Detection Kit, 500 Assay Points
AlphaLISA Human IL-17A High Performance & Biotin Free Detection Kit, 500 Assay Points

Resources

Are you looking for resources, click on the resource type to explore further.

  • - すべて -:-:- Any -
  • Application Note:-:3
  • Flyer:-:1
  • Guide:-:1
1-1 of 1 Resources
Application Note Icon
Application Note
Homogeneous detection of cytokines from PBMC supernatants using AlphaLISA High Performance assays

Cytokines play an essential role in inflammatory processes, leading to their involvement in viral and bacterial infections, as...

Learn more

How can we help you?

We are here to answer your questions.

Contact sales I would like more product information Contact customer care Get technical support
Get Help Illustration Get Help Illustration
Scroll Icon
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.